Do you have the same question? Follow this Question
Nov 28, 2024 - 10:24 AM
We’ve provided several answers to questions related to Bevespi Aerosphere (Glycopyrrolate/Formoterol fumarte) , see some other helpful Q&A related to this product.
Question: How many times a day can you use Bevespi?
Answer: Bevespi Aerosphere is typically used twice a day, once in the morning and once in the evening. It is important to follow your healthcare provider's instructions and not exceed the recommended dosage.
Question: What conditions should you inform your doctor about before using Bevespi Aerosphere?
Answer: Inform your doctor if you have heart problems, high blood pressure, glaucoma, prostatic hyperplasia, bladder-neck obstruction, convulsive disorders, thyroid problems, diabetes, or ketoacidosis. This helps ensure safe and effective use of the medication.
Question: What are common side effects of Bevespi Aerosphere?
Answer: Common side effects of Bevespi Aerosphere include cough and urinary tract infection. Knowing these potential side effects can help users monitor their health and seek medical advice if necessary.
Question: What is the recommended dosage for maintenance treatment with Bevespi Aerosphere?
Answer: The recommended dosage for maintenance treatment of COPD with Bevespi Aerosphere is 2 puffs by mouth twice daily. This routine helps maintain open airways and improve breathing over time.
Question: How is Bevespi Aerosphere administered?
Answer: Bevespi Aerosphere is administered via inhalation using a pressurized metered dose inhaler. This method ensures direct delivery of the medication to the lungs for effective treatment of COPD.
Question: What is the KEGG identifier for Bevespi Aerosphere?
Answer: The KEGG identifier for Bevespi Aerosphere is D00540. This identifier is useful for accessing detailed drug information in the Kyoto Encyclopedia of Genes and Genomes.
Question: What is the ChEBI identifier for Bevespi Aerosphere?
Answer: The ChEBI identifier for Bevespi Aerosphere is 90972. This identifier is useful for accessing detailed chemical and biological information about the drug in the ChEBI database.
Question: What is the PubChem CID for Bevespi Aerosphere?
Answer: The PubChem CID for Bevespi Aerosphere is 3494. This identifier is useful for looking up detailed chemical information about the drug in scientific databases.
Question: What is the dosage strength of Bevespi Aerosphere?
Answer: Bevespi Aerosphere is available in two dosage strengths: 10.7g of 7.2mcg/5mcg per inhaler (120 doses) and 10.7g of 9mcg/4.8mcg per inhaler (120 doses). These dosages provide flexibility in treatment based on patient needs.
Question: What is the elimination half-life of Bevespi Aerosphere?
Answer: The elimination half-life of Bevespi Aerosphere is between 0.6 to 1.2 hours. This indicates how long it takes for half of the drug to be eliminated from the body, which is crucial for dosing schedules.
Question: What is the formula for Bevespi Aerosphere?
Answer: The formula for Bevespi Aerosphere is C19H28BrNO3. This formula represents the molecular composition of the medication, essential for understanding its chemical properties and potential interactions.
View all Bevespi Aerosphere (Glycopyrrolate/Formoterol fumarte) Questions & Answers
